Filing Details

Accession Number:
0001209191-21-065673
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-18 21:12:25
Reporting Period:
2021-11-17
Accepted Time:
2021-11-18 21:12:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661460 Poseida Therapeutics Inc. PSTX Biological Products, (No Disgnostic Substances) (2836) 472846548
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1816804 D. Kerry Ingalls C/O Poseida Therapeutics, Inc.
9390 Towne Centre Drive, Ste 200
San Diego CA 92121
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-17 2,000 $7.00 2,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct